Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2024 | May 03, 2024 | |
Document and Entity Information | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2024 | |
Document Transition Report | false | |
Entity File Number | 001-41059 | |
Entity Registrant Name | Lulu’s Fashion Lounge Holdings, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 20-8442468 | |
Entity Address, Address Line One | 195 Humboldt Avenue | |
Entity Address, City or Town | Chico | |
Entity Address State Or Province | CA | |
Entity Address, Postal Zip Code | 95928 | |
City Area Code | 530 | |
Local Phone Number | 343-3545 | |
Title of 12(b) Security | Common stock, $0.001 par value per share | |
Trading Symbol | LVLU | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 41,326,868 | |
Entity Central Index Key | 0001780201 | |
Current Fiscal Year End Date | --12-29 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 5,489 | $ 2,506 |
Accounts receivable | 5,212 | 3,542 |
Inventory, net | 41,271 | 35,472 |
Assets for recovery | 5,062 | 3,111 |
Income tax refund receivable | 2,889 | 2,510 |
Prepaids and other current assets | 5,297 | 5,379 |
Total current assets | 65,220 | 52,520 |
Property and equipment, net | 4,694 | 4,712 |
Goodwill | 35,430 | 35,430 |
Tradename | 18,509 | 18,509 |
Intangible assets, net | 3,147 | 3,263 |
Lease right-of-use assets | 28,182 | 29,516 |
Other noncurrent assets | 5,451 | 5,495 |
Total assets | 160,633 | 149,445 |
Current liabilities: | ||
Accounts payable | 8,312 | 8,900 |
Accrued expenses and other current liabilities | 30,077 | 18,343 |
Returns reserve | 15,858 | 7,854 |
Stored-value card liability | 13,209 | 13,142 |
Revolving line of credit | 6,000 | 8,000 |
Lease liabilities, current | 5,530 | 5,648 |
Total current liabilities | 78,986 | 61,887 |
Lease liabilities, noncurrent | 23,863 | 25,427 |
Other noncurrent liabilities | 38 | 1,179 |
Total liabilities | 102,887 | 88,493 |
Commitments and Contingencies (Note 7) | ||
Stockholders' equity: | ||
Preferred stock: $0.001 par value, 10,000,000 shares authorized, and no shares issued or outstanding | ||
Common stock: $0.001 par value, 250,000,000 shares authorized; and 41,255,966 and 40,618,206 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 41 | 41 |
Additional paid-in capital | 256,646 | 254,116 |
Accumulated deficit | (198,941) | (193,205) |
Total stockholders' equity | 57,746 | 60,952 |
Total liabilities and stockholders' equity | $ 160,633 | $ 149,445 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2024 | Dec. 31, 2023 |
Condensed Consolidated Balance Sheets | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock issued | 0 | 0 |
Preferred stock outstanding | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 250,000,000 | 250,000,000 |
Common stock, shares issued | 41,255,966 | 40,618,206 |
Common stock, shares outstanding | 41,255,966 | 40,618,206 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Apr. 02, 2023 | |
Condensed Consolidated Statements of Operations and Comprehensive Loss | ||
Net revenue | $ 77,259 | $ 90,976 |
Cost of revenue | 44,613 | 53,015 |
Gross profit | 32,646 | 37,961 |
Selling and marketing expenses | 17,693 | 19,489 |
General and administrative expenses | 21,111 | 24,348 |
Loss from operations | (6,158) | (5,876) |
Other income (expense), net: | ||
Interest expense | (383) | (523) |
Other income, net | 226 | 73 |
Loss before benefit for income taxes | (6,315) | (6,326) |
Income tax benefit | 579 | 708 |
Net loss and comprehensive loss | $ (5,736) | $ (5,618) |
Basic loss per share (In dollars per share) | $ (0.15) | $ (0.14) |
Diluted loss per share (In dollars per share) | $ (0.15) | $ (0.14) |
Basic weighted-average shares outstanding (In shares) | 39,450,502 | 39,233,953 |
Diluted weighted-average shares outstanding (In shares) | 39,450,502 | 39,233,953 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Common Stock. | Additional Paid-In Capital | Accumulated Deficit | Total |
Balance at Jan. 01, 2023 | $ 39 | $ 238,725 | $ (173,871) | $ 64,893 |
Balance (in shares) at Jan. 01, 2023 | 39,259,328 | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Issuance of common stock for vesting of restricted stock units (RSUs) | $ 1 | 1 | ||
Issuance of common stock for vesting of restricted stock units (RSUs) (shares) | 491,769 | |||
Issuance of common stock for special compensation award (shares) | 208,914 | |||
Issuance of common stock for employee stock purchase plan (ESPP) | 269 | 269 | ||
Issuance of common stock for employee stock purchase plan (ESPP) (in shares) | 47,502 | |||
Shares withheld for withholding tax on RSUs | (662) | (662) | ||
Shares withheld for withholding tax on RSUs (in shares) | (277,606) | |||
Forfeited shares of restricted stock (in shares) | (2,720) | |||
Equity-based compensation | 4,892 | 4,892 | ||
Net loss and comprehensive loss | (5,618) | (5,618) | ||
Balance at Apr. 02, 2023 | $ 40 | 243,224 | (179,489) | 63,775 |
Balance (in shares) at Apr. 02, 2023 | 39,727,187 | |||
Balance at Jan. 01, 2023 | $ 39 | 238,725 | (173,871) | 64,893 |
Balance (in shares) at Jan. 01, 2023 | 39,259,328 | |||
Balance at Dec. 31, 2023 | $ 41 | 254,116 | (193,205) | 60,952 |
Balance (in shares) at Dec. 31, 2023 | 40,618,206 | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Issuance of common stock for vesting of restricted stock units (RSUs) (shares) | 983,460 | |||
Issuance of common stock for employee stock purchase plan (ESPP) | 167 | 167 | ||
Issuance of common stock for employee stock purchase plan (ESPP) (in shares) | 52,043 | |||
Shares withheld for withholding tax on RSUs | (660) | (660) | ||
Shares withheld for withholding tax on RSUs (in shares) | (396,708) | |||
Forfeited shares of restricted stock (in shares) | (1,035) | |||
Equity-based compensation | 3,023 | 3,023 | ||
Net loss and comprehensive loss | (5,736) | (5,736) | ||
Balance at Mar. 31, 2024 | $ 41 | $ 256,646 | $ (198,941) | $ 57,746 |
Balance (in shares) at Mar. 31, 2024 | 41,255,966 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Apr. 02, 2023 | |
Cash Flows from Operating Activities | ||
Net loss | $ (5,736) | $ (5,618) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization | 1,339 | 1,121 |
Noncash lease expense | 970 | 864 |
Amortization of debt discount and debt issuance costs | 39 | 40 |
Equity-based compensation expense | 1,934 | 4,698 |
Deferred income taxes | (2,105) | |
Changes in operating assets and liabilities: | ||
Accounts receivable | (1,670) | (3,326) |
Inventories | (5,799) | (8,644) |
Assets for recovery | (1,951) | (2,862) |
Income taxes (receivable) payable | (379) | 1,388 |
Prepaid and other current assets | 82 | (295) |
Accounts payable | (549) | 1,719 |
Accrued expenses and other current liabilities | 20,053 | 17,572 |
Operating lease liabilities | (939) | (803) |
Other noncurrent liabilities | (447) | (44) |
Net cash provided by operating activities | 6,947 | 3,705 |
Cash Flows from Investing Activities | ||
Capitalized software development costs | (397) | (551) |
Purchases of property and equipment | (562) | (518) |
Net cash used in investing activities | (959) | (1,069) |
Cash Flows from Financing Activities | ||
Proceeds from borrowings on revolving line of credit | 10,000 | 2,000 |
Repayments on revolving line of credit | (12,000) | (7,000) |
Proceeds from issuance of common stock under employee stock purchase plan (ESPP) | 167 | 269 |
Principal payments on finance lease obligations | (743) | (245) |
Withholding tax payments related to vesting of RSUs | (429) | (43) |
Other | (7) | |
Net cash used in financing activities | (3,005) | (5,026) |
Net increase (decrease) in cash, cash equivalents and restricted cash | 2,983 | (2,390) |
Cash, cash equivalents and restricted cash at beginning of period | 2,506 | 10,219 |
Cash, cash equivalents and restricted cash at end of period | 5,489 | 7,829 |
Reconciliation of cash and cash equivalents | ||
Cash and cash equivalents | 5,489 | 7,829 |
Total cash and cash equivalents at end of period | 5,489 | 7,829 |
Supplemental Disclosure | ||
Income taxes, net | 250 | 9 |
Interest | 296 | 497 |
Operating leases | 1,388 | 1,298 |
Finance leases | 771 | 245 |
Supplemental Disclosure of Non-Cash Investing and Financing Activities | ||
Right-of-use assets acquired under operating lease obligations | 17 | |
Assets acquired under finance lease obligations | 69 | |
Purchases of property and equipment included in accounts payable and accrued expenses | $ 53 | $ 35 |
Description of Business, Organi
Description of Business, Organization and Liquidity | 3 Months Ended |
Mar. 31, 2024 | |
Description of Business, Organization and Liquidity | |
Description of Business, Organization and Liquidity | 1. Organization and Business Pursuant to a reorganization, Lulu’s Fashion Lounge Holdings, Inc., a Delaware Corporation (“Lulus”, “we”, “our”, or the “Company”), was formed on August 25, 2017 as a holding company and its primary asset is an indirect membership interest in Lulu’s Fashion Lounge, LLC (“Lulus LLC”). Prior to the Company’s initial public offering, the Company was majority-owned by Lulu’s Holdings, L.P. (the “LP”). In connection with the Company’s initial public offering, the LP was liquidated. Lulus LLC was founded in 1996, starting as a vintage boutique in Chico, CA that began selling online in 2005 and transitioned to a purely online business in 2008. The LP was formed in 2014 as a holding company and purchased 100% of Lulus LLC’s outstanding common stock in 2014. The Company, through Lulus LLC, is a customer-driven, digitally-native, attainable luxury fashion brand for women, offering modern, unapologetically feminine designs at accessible prices for all of life’s fashionable moments. Impact of Macroeconomic Trends on Business Changing macroeconomic factors, including inflation, interest rates, student loan repayment resumption, as well as world events, wars and domestic and international conflicts, affect overall consumer confidence with respect to current and future economic conditions and continue to impact our sales as discretionary consumer spending levels and shopping behavior fluctuate with these factors. We continue to respond to these factors, as needed, by taking appropriate pricing, promotional and other actions to stimulate customer demand. These factors may continue to have an impact on our business, results of operations, our growth and financial condition. Liquidity The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of March 31, 2024, the Company had total cash and cash equivalents of $5.5 million and amounts due under the revolving line of credit of $6.0 million In November 2021 the Company entered into a Credit Agreement (the “2021 Credit Agreement”) to provide a Revolving Facility (the “2021 Revolving Facility”) that provides for borrowings up to $50.0 million. The 2021 Credit Agreement contains various financial covenants and matures on November 15, 2024 as described in Note 5, Debt The Company is evaluating sources of debt financing. However, the Company believes the cash on hand and cash provided by operations in conjunction with certain cash conservation measures to be taken as necessary, including adjustments to marketing and other variable and capital spend, will enable the Company to meet its obligations as they become due within one year. The condensed consolidated financial statements do not reflect any adjustments relating to the outcome of this uncertainty. |
Significant Accounting Policies
Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2024 | |
Significant Accounting Policies | |
Significant Accounting Policies | 2. Basis of Presentation and Fiscal Year The Company’s fiscal year consists of a 52-week or 53-week period ending on the Sunday nearest December 31. The fiscal years ending December 29, 2024 and ended December 31, 2023 consist of 52-weeks. The condensed consolidated financial statements and accompanying notes include the accounts of the Company and its wholly owned subsidiaries, after elimination of all intercompany balances and transactions. The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the Unites States of America (“GAAP”) and the requirements of the SEC for interim reporting. As permitted under these rules, certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. The interim condensed consolidated financial statements are unaudited. The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2024 and its results of operations for the thirteen weeks ended March 31, 2024 and April 2, 2023 and its cash flows for the thirteen weeks ended March 31, 2024 and April 2, 2023. The results of operations for the thirteen weeks ended March 31, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending December 29, 2024 or for any other future annual or interim period The condensed consolidated balance sheet as of December 31, 2023 was derived from the Company’s audited consolidated financial statements, which are included in the Company’s Annual Report on Form 10-K as filed with the SEC on March 6, 2024. Significant Accounting Policies The significant accounting policies used in preparation of these condensed consolidated financial statements are consistent with those discussed in Note 2 to the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, except as noted below and within the "Adopted and Recently Issued Accounting Pronouncements" section. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The significant estimates and assumptions made by management relate to sales return reserves and related assets for recovery, lease right-of-use assets and related lease liabilities, income tax valuation allowance and fair value of equity awards. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Concentration of Credit Risks Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents and restricted cash. Such amounts may exceed federally insured limits. The Company reduces credit risk by depositing its cash with a major credit-worthy financial institution within the United States. To date, the Company has not experienced any losses on its cash deposits. As of March 31, 2024 and December 31, 2023, no single customer represented greater than 10% of the Company’s accounts receivable balance. No customer accounted for greater than 10% of the Company’s net revenue during the thirteen weeks ended March 31, 2024 and April 2, 2023. Leases Contracts that have been determined to convey the right to use an identified asset are evaluated for classification as an operating or finance lease. For the Company’s operating and finance leases, the Company records a lease liability based on the present value of the lease payments at lease inception. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, the Company uses its incremental borrowing rate (“IBR”). The determination of the IBR requires judgment and is primarily based on publicly-available information for companies within similar industries and with similar credit profiles. The Company adjusts the rate for the impact of collateralization, the lease term and other specific terms included in each lease arrangement. The IBR is determined at the lease commencement and is subsequently reassessed upon a modification to the lease arrangement. The right-of-use asset is recorded based on the corresponding lease liability at lease inception, adjusted for payments made to the lessor at or before the commencement date, initial direct costs incurred and any tenant incentives allowed for under the lease. The Company does not include optional renewal terms or early termination provisions unless the Company is reasonably certain such options would be exercised at the inception of the lease. Lease right-of-use assets, current portion of lease liabilities, and lease liabilities, net of current portion are included on the condensed consolidated balance sheets. Fixed lease expense for operating leases is recognized on a straight-line basis, unless the right-of-use assets have been impaired, over the reasonably assured lease term based on the total lease payments and is included in operating expenses in the condensed consolidated statements of operations and comprehensive loss. Fixed and variable lease expense on operating leases is recognized within operating expenses in the condensed consolidated statements of operations and comprehensive loss. Finance lease expenses are recognized on a straight-line basis. Fixed and variable expenses are captured within interest expense and depreciation expense, which has components within general and administrative expenses and cost of revenue. The Company’s non-lease components are primarily related to maintenance, insurance and taxes, which varies based on future outcomes and is thus recognized in lease expense when incurred. Revenue Recognition The Company generates revenue primarily from the sale of merchandise products directly to end customers. The sale of products is a distinct performance obligation, and revenue is recognized at a point in time when control of the promised product is transferred to customers, which the Company determined occurs upon shipment based on its evaluation of the related shipping terms. Revenue is recognized in an amount that reflects the transaction price consideration that the Company expects to receive in exchange for those products. The Company’s payment terms are typically at the point of sale for merchandise product sales. The Company elected to exclude from revenue taxes assessed by governmental authorities, including value-added and other sales-related taxes, that are imposed on and concurrent with revenue-producing activities. The Company has elected to apply the practical expedient, relative to e-commerce sales, which allows an entity to account for shipping and handling as fulfillment activities, and not a separate performance obligation. Accordingly, the Company recognizes revenue for only one performance obligation, the sale of the product, at shipping point (when the customer gains control). Shipping and handling costs associated with outbound freight are accounted for as fulfillment costs and are included in cost of goods sold. The Company has elected to apply the practical expedient to expense costs as incurred for incremental costs to obtain a contract when the amortization period would have been one year or less. Revenue from merchandise product sales is reported net of sales returns, which includes an estimate of future returns based on historical return rates, with a corresponding reduction to cost of sales. There is judgment in utilizing historical trends for estimating future returns. The Company’s refund liability for sales returns is included in the returns reserve on its condensed consolidated balance sheets and represents the expected value of the refund that will be due to the Company’s customers. The Company also has corresponding assets for recovery that represent the expected net realizable value of the merchandise inventory to be returned. The Company sells stored-value gift cards to customers and offers merchandise credit stored-value cards for certain returns. Such stored-value cards do not have an expiration date. The Company recognizes revenue from stored-value cards when the card is redeemed by the customer. The Company has determined that sufficient evidence exists to support an estimate for stored-value card breakage. Subject to requirements to remit balances to governmental agencies, breakage is recognized as revenue in proportion to the pattern of rights exercised by the customer, which is substantially within thirty-six months from the date of issuance. The amount of breakage recognized in revenue during the thirteen weeks ended March 31, 2024 and April 2, 2023 was not material. The Company has two types of contractual liabilities: (i) cash collections from its customers prior to delivery of products purchased (“deferred revenue”), which are initially recorded within accrued expenses and recognized as revenue when the products are shipped, (ii) unredeemed gift cards and online store credits, which are initially recorded as a stored-value card liability and are recognized as revenue in the period they are redeemed. The following table summarizes the significant changes in the contract liabilities balances included in accrued expenses and other current liabilities during the thirteen weeks ended March 31, 2024 and April 2, 2023 (in thousands): Deferred Stored-Value Revenue Cards Balance as of December 31, 2023 $ 50 $ 13,142 Revenue recognized that was included in contract liability balance at the beginning of the period (50) (1,549) Increase due to cash received, excluding amounts recognized as revenue during the period 230 1,616 Balance as of March 31, 2024 230 13,209 Deferred Stored-Value Revenue Cards Balance as of January 1, 2023 $ 69 $ 10,828 Revenue recognized that was included in contract liability balance at the beginning of the period (69) (1,720) Increase due to cash received, excluding amounts recognized as revenue during the period 122 2,022 Balance as of April 2, 2023 122 11,130 Selling and Marketing Expenses Advertising costs included in selling and marketing expenses were $13.0 million and $15.1 million for the thirteen weeks ended , respectively. Net loss Per Share Attributable to Common Stockholders Basic net loss per share attributable to common stockholders is computed using net loss attributable to common stockholders divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share attributable to common stockholders represents net loss attributable to common stockholders divided by the weighted average number of common shares outstanding during the period, including the effects of any dilutive securities outstanding. The following table presents the calculation of basic and diluted weighted average shares used to compute net loss per share attributable to common stockholders: Thirteen Weeks Ended March 31, 2024 April 2, 2023 Weighted average shares used to compute net loss per share attributable to common stockholders – Basic 39,450,502 39,233,953 Dilutive securities: Stock options — — Unvested restricted stock — — Unvested Restricted Stock Units (RSUs) — — Performance Stock Units (PSUs) — — Special compensation awards - — Employee Stock Purchase Plan (ESPP) shares — — 2023 Bonus Plan — — Weighted average shares used to compute net loss per share attributable to common stockholders – Diluted 39,450,502 39,233,953 The following securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (on an as-converted basis): Thirteen Weeks Ended March 31, 2024 April 2, 2023 Stock options 161,397 161,397 Unvested restricted stock 15,617 66,313 Unvested RSUs 4,453,480 4,024,510 PSUs 2,161,571 1,811,571 ESPP shares 161,237 146,535 2023 Bonus Plan 95,912 — Total 7,049,214 6,210,326 Goodwill and Intangible Assets The Company tests for goodwill impairment at the reporting unit level on the first day of the fourth quarter of each year and between annual tests if significant indicators exist that would suggest the Company's goodwill and intangible assets could potentially be impaired. The Company monitors changing business conditions as well as industry and economic factors, among others, for events which could trigger the need for an interim impairment analysis. The Company concluded that a sustained decline in its stock price coupled with continuing net losses, were significant enough factors to warrant an impairment analysis of its goodwill, tradename and intangible assets (which constitutes the Company's sole reporting unit) during the thirteen weeks ended March 31, 2024. Accordingly, the Company performed an interim quantitative assessment as of March 31, 2024 using a market-based quantitative assessment utilizing a combination of the (i) the guideline public company method applying revenue and EBITDA multiples of similar companies and (ii) the discounted cash flow method. The fair value determination used in the impairment assessment requires estimates of the fair values based on present value or other valuation techniques or a combination thereof, necessitating subjective judgments and assumptions by management. These estimates and assumptions could result in significant differences to the amounts reported if underlying circumstances were to change. The fair value exceeded the carrying value by approximately 17% and the Company concluded that no impairment relating to the goodwill, tradename and intangible assets existed as of March 31, 2024. Recently Adopted Accounting Pronouncements The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. Recently Issued Accounting Pronouncements In November 2023, FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures In December 2023, FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, In March 2024, FASB issued ASU 2024-01, Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards, In March 2024, FASB issued ASU 2024-02, Codification Improvements—Amendments to Remove References to the Concepts Statements, |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2024 | |
Fair Value Measurements | |
Fair Value Measurements | 3. The Company’s financial instruments consist of cash and cash equivalents, restricted cash, accounts payable, accrued expenses and revolving line of credit. As of March 31, 2024 and December 31, 2023, the carrying values of cash and cash equivalents, restricted cash, accounts payable and accrued expenses and other current liabilities approximate fair value due to their short-term maturities. The fair value of the Company’s 2021 Revolving Facility that provides for borrowings up to $50.0 million (see Note 5, Debt |
Balance Sheet Components
Balance Sheet Components | 3 Months Ended |
Mar. 31, 2024 | |
Balance Sheet Components | |
Balance Sheet Components | 4. Property and Equipment, net Property and equipment, net consisted of the following (in thousands): Estimated Useful Lives March 31, December 31, in Years 2024 2023 Leasehold improvements 3 - 9 $ 4,875 $ 4,314 Equipment 3 - 7 3,122 3,053 Furniture and fixtures 3 - 7 2,019 2,151 Construction in progress 234 688 Total property and equipment 10,250 10,206 Less: accumulated depreciation and amortization (5,556) (5,494) Property and equipment, net $ 4,694 $ 4,712 Depreciation and amortization of property and equipment for the thirteen weeks ended March 31, 2024 and April 2, 2023 was $0.8 million and $0.7 million, respectively Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): March 31, December 31, 2024 2023 Accrued compensation and benefits $ 3,633 $ 5,057 Accrued marketing 7,241 5,002 Accrued inventory 12,815 4,151 Accrued freight 2,751 1,940 Other 3,637 2,193 Accrued expenses and other current liabilities $ 30,077 $ 18,343 |
Debt
Debt | 3 Months Ended |
Mar. 31, 2024 | |
Debt | |
Debt | 5. 2021 Credit Agreement and Revolving Facility During November 2021, the Company entered into the 2021 Credit Agreement with Bank of America to provide the 2021 Revolving Facility that provides for borrowings up to $50.0 million. During the term of the 2021 Credit Agreement, the Company can increase the aggregate amount of the 2021 Revolving Facility up to an additional $25.0 million (for maximum aggregate lender commitments of up to $75.0 million), subject to the satisfaction of certain conditions under the 2021 Credit Agreement, including obtaining the consent of the administrative agent and an increased commitment from existing or new lenders. In addition, the 2021 Credit Agreement may be used to issue letters of credit up to $7.5 million (the “Letter of Credit”). During the thirteen weeks ended March 31, 2024, the Company borrowed $10.0 million under the 2021 Revolving Facility and repaid $12.0 million of the outstanding balance. The 2021 Revolving Facility matures on November 15, 2024, while the Letter of Credit matures on November 8, 2024. As of March 31, 2024, the Company had $0.3 million outstanding under the Letter of Credit. Subject to the satisfaction of certain conditions under the 2021 Credit Agreement, as of March 31, 2024, the Company had $43.7 million available for borrowing under the 2021 Revolving Facility and $7.2 million available to issue letters of credit. All borrowings under the 2021 Credit Agreement accrue interest at a rate equal to, at the Company’s option, either (x) the term daily SOFR, plus the applicable SOFR adjustment plus a margin of 1.75% per annum or (y) the base rate plus a margin of 0.75% (with the base rate being the highest of the federal funds rate plus 0.50%, the prime rate and term SOFR for a period of one month plus 1.00%). The 2021 Revolving Facility contains a financial maintenance covenant requiring a maximum total leverage ratio of no more than 2.50:1.00, stepping down to 2.00:1.00 after 18 months. Additionally, a commitment fee of 37.5 basis points will be assessed on unused commitments under the 2021 Revolving Facility, taking into account the sum of outstanding borrowings and letter of credit obligations. As of March 31, 2024, the interest rate for the 2021 Revolving Facility was 7.2%, and during thirteen weeks ended March 31, 2024, the weighted average interest rate for the 2021 Revolving Facility was 8.3%. Amounts borrowed under the 2021 Credit Agreement are collateralized by all assets of the Company and contains various financial and non-financial covenants for reporting, protecting and obtaining adequate insurance coverage for assets collateralized and for coverage of business operations, and complying with requirements, including the payment of all necessary taxes and fees for all federal, state and local government entities. Immediately upon the occurrence and during the continuance of an event of default, including the noncompliance with the above covenants, the lender may increase the interest rate per annum by 2.0% above the rate that would be otherwise applicable. As of March 31, 2024, management has determined that the Company was in compliance with all financial covenants. Debt Discounts and Issuance Costs Debt discounts and issuance costs are deferred and amortized over the life of the related loan using the effective interest method. The associated expense is included in interest expense in the consolidated statements of operations and comprehensive loss. Debt issuance costs related to the 2021 Revolving Facility, are included in other non-current assets in the consolidated balance sheets. As of March 31, 2024 and December 31, 2023, unamortized debt issuance costs recorded within other non-current assets were $0.1 million and $0.1 million, respectively. |
Leases
Leases | 3 Months Ended |
Mar. 31, 2024 | |
Leases | |
Leases | 6 . On January 3, 2022, the Company adopted ASC 842 using the alternative transition method and applied the standard only to leases that existed at that date. Under the alternative transition method, the Company did need to restate the comparative periods in transition and will continue to present financial information and disclosures for periods before January 3, 2022, in accordance with FASB ASC 840, Leases The Company is a lessee under various lease agreements. The determination of whether an arrangement contains a lease and the lease classification is made at lease commencement (date on which a lessor makes an underlying asset available for use by the lessee). At lease commencement, the Company also measures and recognizes a right-of-use asset, representing the Company’s right to use the underlying asset, and a lease liability, representing the Company’s obligation to make lease payments under the terms of the arrangement. The lease term is defined as the noncancelable portion of the lease term plus any periods covered by an option to extend the lease if it is reasonably certain that the option will be exercised. For the purposes of recognizing right-of-use assets and lease liabilities associated with the Company’s leases, the Company has elected the practical expedient of not recognizing a right-of-use asset or lease liability for short-term leases, which are leases with a term of 12 months or less. The Company has multiple finance leases and operating leases that are combined and included in the lease right-of-use assets, lease liabilities, current, and lease liabilities, noncurrent on the Company’s condensed consolidated balance sheets. The Company primarily leases its distribution facilities, corporate offices and retail stores under operating lease agreements expiring on various dates through December 2031, most of which contain options to extend. In addition to payment of base rent, the Company is also required to pay property taxes, insurance, and common area maintenance expenses. The Company records lease expense on a straight-line basis over the term of the lease. The Company had immaterial remaining obligations for the base rent related to the short-term leases as of March 31, 2024 and April 2, 2023. The Company also leases equipment under finance lease agreements expiring on various dates through May 2028. As of March 31, 2024, the future minimum lease payments for the Company’s operating and finance leases for each of the fiscal years were as follows (in thousands): Fiscal Year: Operating Leases Finance Leases Total 2024 (remaining nine months) $ 4,252 $ 1,006 $ 5,258 2025 6,263 1,504 7,767 2026 4,970 252 5,222 2027 5,138 74 5,212 2028 5,252 6 5,258 Thereafter 6,380 — 6,380 Total undiscounted lease payment 32,255 2,842 35,097 Present value adjustment (5,582) (122) (5,704) Total lease liabilities 26,673 2,720 29,393 Less: lease liabilities, current (4,106) (1,424) (5,530) Lease liabilities, noncurrent $ 22,567 $ 1,296 $ 23,863 Under the terms of the remaining lease agreements, the Company is also responsible for certain variable lease payments that are not included in the measurement of the lease liability, including non-lease components such as common area maintenance fees, taxes, and insurance. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2024 | |
Commitments and Contingencies | |
Commitments and Contingencies | 7 . Litigation and Other From time to time, the Company may be a party to litigation and subject to claims, including employment claims, wage and hour claims, intellectual property claims, privacy claims, contractual and commercial disputes and other matters that arise in the ordinary course of our business. The Company accrues a liability when management believes information available prior to the issuance of the consolidated financial statements indicates it is probable a loss has been incurred as of the date of the consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although the results of litigation and claims are inherently unpredictable, management concluded that it was not probable that it had incurred a material loss during the periods presented related to such loss contingencies. Therefore, the Company has not recorded a reserve for any contingencies. During the normal course of business, the Company may be a party to claims that may not be covered wholly or partially by insurance. While the ultimate liability, if any, arising from these claims cannot be predicted with certainty, management does not believe that the resolution of any such claims would have a material adverse effect on the Company’s condensed consolidated financial statements. As of March 31, 2024, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that are expected to have a material adverse impact on its condensed consolidated financial statements. Indemnification The Company also maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify the Company’s directors and officers. To date, the Company has not incurred any material costs and has not accrued any liabilities in the condensed consolidated financial statements as a result of these provisions. |
Preferred Stock
Preferred Stock | 3 Months Ended |
Mar. 31, 2024 | |
Preferred Stock | |
Preferred Stock | 8. Pursuant to the Company’s amended and restated certificate of incorporation, the Company is authorized to issue 10,000,000 shares of preferred stock having a par value of $0.001 per share. The Company’s Board of Directors has the authority to issue preferred stock and to determine the rights, preferences, privileges, and restrictions, including voting rights, of those shares. As of March 31, 2024 and December 31, 2023, no shares of preferred stock were issued and outstanding . |
Common Stock
Common Stock | 3 Months Ended |
Mar. 31, 2024 | |
Common Stock | |
Common Stock | 9. The Company has authorized the issuance of 250,000,000 shares of common stock, $0.001 par value ("common stock") as of March 31, 2024 and December 31, 2023. Holders of common stock are entitled to one vote per share on all matters to be voted upon by the stockholders of the Company. Subject to the preferences that may be applicable to any outstanding share of preferred stock, the holders of common stock are entitled to receive dividends, if any, as may be declared by the Board of Directors. No dividends have been declared to date. As of March 31, 2024, the Company has reserved 161,397 shares of common stock for issuance upon the exercise of stock options, and 1,704,230 shares of common stock available for future issuance under the Lulu's Fashion Lounge Holdings, Inc. Omnibus Equity Plan (the “Omnibus Equity Plan”) and 1,368,288 shares of common stock available for future issuance under the 2021 Employee Stock Purchase Plan (the “ESPP”), respectively. Both equity plans are further described in Note 10, Equity-Based Compensation. |
Equity-Based Compensation
Equity-Based Compensation | 3 Months Ended |
Mar. 31, 2024 | |
Equity-Based Compensation | |
Equity-Based Compensation | 10 . Omnibus Equity Plan and Employee Stock Purchase Plan In connection with the closing of the IPO, the Company adopted the Omnibus Equity Plan and ESPP. Under the Omnibus Equity Plan, incentive awards may be granted to employees, directors, and consultants of the Company. The Company initially reserved 3,719,000 shares of common stock for future issuance under the Omnibus Equity Plan, including any shares subject to awards under the 2021 Equity Incentive Plan (the “2021 Equity Plan”) that are forfeited or lapse unexercised. The number of shares reserved for issuance under the Omnibus Equity Plan will automatically increase on the first day of each fiscal year, starting in 2022 and continuing through 2031, by a number of shares equal to (a) 4% of the total number of shares of the Company’s common stock outstanding on the last day of the immediately preceding fiscal year or (b) such smaller number of shares as determined by the Company’s Board of Directors. Under the ESPP, the Company initially reserved 743,803 shares of common stock for future issuance. The number of shares of common stock reserved for issuance will automatically increase on the first day of each fiscal year beginning in 2022 and ending in 2031, by a number of shares equal to (a) 1% of the total number of shares of the Company’s common stock outstanding on the last day of the immediately preceding fiscal year or (b) such smaller number of shares as determined by the Company’s Board of Directors. On April 1, 2022, the Company filed a Registration Statement on Form S-8 with the SEC for the purpose of registering an additional 5,921,056 shares of the Company’s common stock, inclusive of 1,536,845 and 384,211 shares associated with automatic increases that occurred on January 3, 2022 under the Omnibus Equity Plan and ESPP, respectively. This registration also included 3,200,000 and 800,000 shares for the Omnibus Equity Plan and the ESPP, respectively, representing two years’ worth of estimated future automatic increases in availability for these plans. On March 8, 2023, the Company’s Board of Directors approved the Fiscal 2023 Bonus Plan (“2023 Bonus Plan”) that granted RSUs to eligible employees on April 1, 2024, instead of the typical cash bonus. For the thirteen weeks ended March 31, 2024, equity-based compensation expense for the 2023 Bonus Plan was reversed by $0.1 million to reflect the actual bonus distribution. A s of March 31, 2024, the unrecognized equity-based compensation expense for 2023 Bonus Plan was immaterial. On April 1, 2024, 95,912 fully vested RSUs were awarded to eligible employees under the 2023 Bonus Plan . On June 29, 2023, the Company filed a Registration Statement on Form S-8 with the SEC for the purpose of registering an additional 2,000,000 shares of the Company's common stock under the Omnibus Equity Plan corresponding to the increase in shares approved by stockholders at the 2023 annual meeting of stockholders. As of March 31, 2024, the Company had 1,704,230 and 1,368,288 shares available for issuance under the Omnibus Equity Plan and ESPP, respectively. The compensation committee of the Company’s Board of Directors (the “Compensation Committee”) administers the Omnibus Equity Plan and determines to whom awards will be granted, the exercise price of any options, the vesting schedule and the other terms and conditions of the awards granted under the Omnibus Equity Plan. The Compensation Committee may or may not issue the full number of shares that are reserved for issuance. The Company’s initial ESPP offering period commenced on August 26, 2022. The ESPP consists of consecutive, overlapping 12-month offering periods that begin on each August 26 and February 26 during the term of the ESPP, and end on each August 25 and February 25 occurring 12 months later, as applicable. Each offering period is comprised of two consecutive six-month purchase periods that begin on each August 26 and February 26 within each offering period and end on each February 25 and August 25, respectively, thereafter. The duration and timing of offering periods and purchase periods may be changed by the Company’s Board of Directors or Compensation Committee at any time. The ESPP allows participants to purchase shares of the Company’s common stock at a 15 percent discount from the lower of the Company’s stock price on (i) the first day of the offering period or on (ii) the last day of the purchase period and includes a rollover mechanism for the purchase price if the stock price on the purchase date is less than the stock price on the offering date. The ESPP also allows participants to reduce their percentage election once during the offering period, but they cannot increase their election until the next offering period. The Company recognizes equity-based compensation expense related to shares issued pursuant to the ESPP on a graded vesting approach over each offering period. For the thirteen weeks ended March 31, 2024 and April 2, 2023, equity-based compensation expense related to our ESPP was immaterial and $0.1 million, respectively. During the thirteen weeks ended March 31, 2024 and April 2, 2023, the Company issued 52,043 shares and 47,502 shares, respectively, pursuant to the ESPP six-month purchase period ended February 26, 2024 and February 25, 2023, respectively. The Company used the Black-Scholes model to estimate the fair value of the purchase rights under the ESPP. For the thirteen weeks ended March 31, 2024, the Company utilized the following assumptions: Expected term (in years) 0.50 to 1.00 Expected volatility 81.95 to 91.30 % Risk-free interest rate 5.03 to 5.34 % Dividend yield - Weighted average fair value per share of ESPP awards granted $ 0.65 to 0.90 2021 Equity Plan During April 2021, the Company’s Board of Directors adopted the 2021 Equity Plan. The 2021 Equity Plan provided for the issuance of incentive stock options, restricted stock, restricted stock units and other stock-based and cash-based awards to the Company’s employees, directors, and consultants. The maximum aggregate number of shares reserved for issuance under the 2021 Equity Plan was 925,000 shares. The options outstanding under the 2021 Equity Plan expire ten years from the date of grant. The Company issues new shares of common stock to satisfy stock option exercises. In connection with the closing of the IPO, no further awards will be granted under the 2021 Equity Plan. Former CEO Stock Options and Special Compensation Awards In April 2021, the Company entered into an Employment Agreement (the “McCreight IPO Employment Agreement”) with the former CEO, David McCreight, and granted stock options under the 2021 Equity Plan to purchase 322,793 shares of common stock with an exercise price of $11.35 per share, which vest based on service and performance conditions. 275,133 of these stock options have only service vesting conditions, and 47,660 of these stock options have both service and performance vesting conditions. In addition, a portion of these stock options were subject to accelerated vesting conditions upon the occurrence of certain future events, which were satisfied upon the closing of the IPO. As previously disclosed on a Form 8-K filed on February 13, 2023 (the “February 13 8-K”), Mr. McCreight voluntarily forfeited 161,396 unvested stock options of the Company. During the thirteen weeks ended April 2, 2023, the forfeiture of 161,396 unvested stock resulted in immediate acceleration of the remaining $1.2 million of compensation expense which was recorded to general and administrative expense. As previously disclosed in the February 13 8-K, the Company and David McCreight also entered into the First Amendment to Lulu’s Fashion Lounge Holdings, Inc. 2021 Equity Incentive Plan Stock Option Agreement that extends the post-termination exercise period of 161,397 vested stock options from 90 days to three Under the McCreight IPO Employment Agreement and subject to ongoing employment, and in light of the closing of the IPO, the former CEO received two bonuses, each of which were settled in 208,914 fully-vested shares of the Company’s common stock. The Company recognized the final $0.4 million of equity-based compensation expense related to this award in the thirteen weeks ended April 2, 2023 Stock Options A summary of stock option activity is as follows (in thousands, except per share amounts and years): Weighted- Weighted- Average Average Exercise Remaining Aggregate Options Price per Contractual Intrinsic Outstanding Option Life (years) Value Balance as of December 31, 2023 161,397 $ 11.35 7.29 Granted — — — Forfeited — — — Outstanding as of March 31, 2024 161,397 $ 11.35 7.04 Exercisable as of March 31, 2024 161,397 $ 11.35 7.04 $ — Vested and expected to vest as of March 31, 2024 161,397 $ 11.35 7.04 $ — Restricted Stock and Restricted Stock Units (“RSUs”) Immediately before the completion of the IPO, the LP was liquidated and the unit holders of the LP received shares of the Company’s common stock in exchange for their units of the LP. The Class P unit holders received 1,964,103 shares of common stock, comprised of 1,536,304 shares of vested common stock and 427,799 shares of unvested restricted stock. Any such shares of restricted stock received in respect of unvested Class P units of the LP are subject to vesting and a risk of forfeiture to the same extent as the corresponding Class P units. s of March 31, 2024, the unrecognized equity-based compensation expense for all restricted stock is $0.3 million and will be recognized over a weighted-average period of 0.58 years The following table summarizes the rollforward of unvested restricted stock during the thirteen weeks ended March 31, 2024: Unvested Weighted- Restricted Average Fair Stock Value per Share Balance at December 31, 2023 23,379 $ 4.54 Restricted stock granted — — Restricted stock vested (6,727) 4.41 Restricted stock forfeited (1,035) 4.54 Balance at March 31, 2024 15,617 $ 4.17 During the thirteen weeks ended March 31, 2024, the Company entered into a second amendment to the employment agreement with Mark Vos, the (the “ ”), under 660,000 RSUs were initially granted, During the thirteen weeks ended March 31, 2024, the Company granted 1,914,071 RSUs to certain executives (inclusive of the aforementioned RSU grants to Mr. Vos, Ms. Deady and Ms. Smith), and employees which are subject to various vesting schedules as set forth in the applicable employment agreement or RSU Award Agreements. During the thirteen weeks ended March 31, 2024, the Company granted 26,616 RSUs to certain directors which vested immediately or pursuant to the Company’s Non-Employee Director Compensation Program. The Company recognized equity-based compensation expense of $1.6 million and $2.8 million during the thirteen weeks ended March 31, 2024, and April 2, 2023, respectively, related to the RSUs. As of March 31, 2024, the unrecognized equity-based compensation expense is $11.3 million and will be recognized over a weighted-average period of 2.30 years . The following table summarizes the roll forward of unvested RSUs during the thirteen weeks ended March 31, 2024: Weighted- Unvested Average Fair RSUs Value per Share Balance at December 31, 2023 3,568,406 $ 3.14 RSUs granted 1,940,687 2.03 RSUs vested (983,460) 2.71 RSUs forfeited (72,153) 2.71 Balance at March 31, 2024 4,453,480 $ 2.76 Performance Stock Units (“PSUs”) Under Crystal Landsem’s 2023 employment agreement (“the CEO Employment Agreement”), Ms. Landsem received a grant of 1,811,571 PSUs on March 5, 2023 which vest in three equal annual installments of 603,857 PSUs subject to the achievement of trailing ten day volume-weighted average price targets of the Company’s common stock and her continued employment on the vesting dates. Under the 2024 President & CIO Employment Agreement, Mr. Vos received a grant of 300,000 PSUs on January 9, 2024 which vest subject to the achievement of trailing ten day volume-weighted average price targets of the Company’s common stock and his continued employment on the vesting dates. Under the 2024 CMO Employment Agreement, Ms. Deady received a grant of 50,000 PSUs on February 16, 2024, which vest subject to the achievement of specified Company trailing twelve month net revenue growth targets and her continued employment on the vesting dates. The Company recognized equity-based compensation expense of $0.6 million and $ 0.2 million during the thirteen weeks ended March 31, 2024, and April 2, 2023, respectively, related to the PSUs. As of March 31, 2024, the unrecognized equity-based compensation expense is $2.1 million for the financial milestones that were considered probable of achievement, which will be recognized over a weighted-average period of 1.71 years. The following table summarizes the rollforward of unvested PSUs during the thirteen weeks ended March 31, 2024: Weighted- Unvested Average Fair PSUs Value per Share Balance at December 31, 2023 1,811,571 $ 2.65 PSUs granted 350,000 1.81 PSUs vested — — PSUs forfeited — — Balance at March 31, 2024 2,161,571 $ 2.51 |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2024 | |
Income Taxes | |
Income Taxes | 11. All of the Company’s loss before income taxes is from the United States. The following table presents the components of the benefit for income taxes (in thousands): Thirteen Weeks Ended March 31, April 2, 2024 2023 Loss before benefit for income taxes $ (6,315) $ (6,326) Benefit for income taxes 579 708 Effective tax rate (9.2) % (11.2) % The Company’s benefit for income taxes during interim reporting periods has historically been calculated by applying an estimate of the annual effective tax rate for the full year to “ordinary” income or loss (pre-tax income or loss excluding unusual or infrequently occurring discrete items) for the reporting period. The Company utilized a discrete effective tax rate method, as allowed by ASC 740-270 “Income Taxes, Interim Reporting,” to calculate taxes for the period ended April 2, 2023. The Company’s pre-tax loss for the period ended April 2, 2023 relative to the Company’s projected pre-tax income for fiscal 2023 yielded an annual effective tax rate, which was not deemed to be appropriate or meaningful. The Company determined that small changes in estimated “ordinary” income would result in significant changes in the estimated annual effective tax rate, and therefore, the historical method would not provide a reliable estimate for the period ended April 2, 2023. At this time, based on evidence currently available, we consider it more likely than not that we will have sufficient taxable income in the future that will allow us to realize the DTAs; however, failure to generate sufficient taxable income could result in some or all DTAs not being utilized in the future. If we are unable to generate sufficient future taxable income, a valuation allowance to reduce our DTAs may be required which would materially increase our expenses in the period the allowance is recognized and materially adversely affect our results of operations and statement of financial conditions. The Company’s pre-tax loss for the period ended March 31, 2024 relative to the Company’s projected pre-tax income for fiscal 2024 yielded an annual effective tax rate, which was deemed to be appropriate and meaningful. Based on this fact, the Company determined that the historical estimated annual effective tax rate method would provide a reliable estimate and was used for calculating the interim provision for the period ended March 31, 2024. For the thirteen weeks ended March 31, 2024, the Company's effective tax rate differs from the federal income tax rate of 21% primarily due to non-deductible executive compensation and non-deductible equity-based compensation expenses. For the thirteen weeks ended April 2, 2023, the Company's effective tax rate differs from the federal income tax rate of 21% primarily due to the increase in the amount of non-deductible executive compensation, relative to the increase in loss before provision for income taxes. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2024 | |
Related Party Transactions | |
Related Party Transactions | 12. Significant Shareholders The Company identified three shareholders with aggregate ownership interest in the Company greater than 10%. The Company reviewed the respective investment portfolio holdings of these shareholders and identified investments in other entities that the Company engages in business with. All of these business relationships were obtained without the support of these shareholders, and as such, are believed to be at terms comparable to those that would be obtained through arm’s length dealings with unrelated third parties. |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2024 | |
Subsequent Events | |
Subsequent Events | 13. Stock Repurchase Program On May 3, 2024, the Company's Board of Directors authorized a stock repurchase program that will allow the Company to repurchase up to an aggregate amount of $2.5 million of its shares of common stock (the "Repurchase Program"). Under the Repurchase Program, the Company may repurchase shares of common stock from time to time in open market transactions or in privately negotiated transactions as permitted under applicable rules and regulations. The timing, volume and nature of such purchases will be determined at the sole discretion of the Company's management at prices the Company considers attractive and in the best interests of the Company, subject to the availability of stock, general market conditions, trading price, alternate uses for capital, the Company's financial performance, and applicable securities laws. The Repurchase Program may be modified, extended or terminated by the Company’s Board of Directors at any time. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2024 | |
Significant Accounting Policies | |
Basis of Presentation and Fiscal Year | Basis of Presentation and Fiscal Year The Company’s fiscal year consists of a 52-week or 53-week period ending on the Sunday nearest December 31. The fiscal years ending December 29, 2024 and ended December 31, 2023 consist of 52-weeks. The condensed consolidated financial statements and accompanying notes include the accounts of the Company and its wholly owned subsidiaries, after elimination of all intercompany balances and transactions. The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the Unites States of America (“GAAP”) and the requirements of the SEC for interim reporting. As permitted under these rules, certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. The interim condensed consolidated financial statements are unaudited. The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2024 and its results of operations for the thirteen weeks ended March 31, 2024 and April 2, 2023 and its cash flows for the thirteen weeks ended March 31, 2024 and April 2, 2023. The results of operations for the thirteen weeks ended March 31, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending December 29, 2024 or for any other future annual or interim period The condensed consolidated balance sheet as of December 31, 2023 was derived from the Company’s audited consolidated financial statements, which are included in the Company’s Annual Report on Form 10-K as filed with the SEC on March 6, 2024. |
Use of Estimates | Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The significant estimates and assumptions made by management relate to sales return reserves and related assets for recovery, lease right-of-use assets and related lease liabilities, income tax valuation allowance and fair value of equity awards. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. |
Concentration of Credit Risks | Concentration of Credit Risks Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents and restricted cash. Such amounts may exceed federally insured limits. The Company reduces credit risk by depositing its cash with a major credit-worthy financial institution within the United States. To date, the Company has not experienced any losses on its cash deposits. As of March 31, 2024 and December 31, 2023, no single customer represented greater than 10% of the Company’s accounts receivable balance. No customer accounted for greater than 10% of the Company’s net revenue during the thirteen weeks ended March 31, 2024 and April 2, 2023. |
Leases | Leases Contracts that have been determined to convey the right to use an identified asset are evaluated for classification as an operating or finance lease. For the Company’s operating and finance leases, the Company records a lease liability based on the present value of the lease payments at lease inception. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, the Company uses its incremental borrowing rate (“IBR”). The determination of the IBR requires judgment and is primarily based on publicly-available information for companies within similar industries and with similar credit profiles. The Company adjusts the rate for the impact of collateralization, the lease term and other specific terms included in each lease arrangement. The IBR is determined at the lease commencement and is subsequently reassessed upon a modification to the lease arrangement. The right-of-use asset is recorded based on the corresponding lease liability at lease inception, adjusted for payments made to the lessor at or before the commencement date, initial direct costs incurred and any tenant incentives allowed for under the lease. The Company does not include optional renewal terms or early termination provisions unless the Company is reasonably certain such options would be exercised at the inception of the lease. Lease right-of-use assets, current portion of lease liabilities, and lease liabilities, net of current portion are included on the condensed consolidated balance sheets. Fixed lease expense for operating leases is recognized on a straight-line basis, unless the right-of-use assets have been impaired, over the reasonably assured lease term based on the total lease payments and is included in operating expenses in the condensed consolidated statements of operations and comprehensive loss. Fixed and variable lease expense on operating leases is recognized within operating expenses in the condensed consolidated statements of operations and comprehensive loss. Finance lease expenses are recognized on a straight-line basis. Fixed and variable expenses are captured within interest expense and depreciation expense, which has components within general and administrative expenses and cost of revenue. The Company’s non-lease components are primarily related to maintenance, insurance and taxes, which varies based on future outcomes and is thus recognized in lease expense when incurred. |
Revenue Recognition | Revenue Recognition The Company generates revenue primarily from the sale of merchandise products directly to end customers. The sale of products is a distinct performance obligation, and revenue is recognized at a point in time when control of the promised product is transferred to customers, which the Company determined occurs upon shipment based on its evaluation of the related shipping terms. Revenue is recognized in an amount that reflects the transaction price consideration that the Company expects to receive in exchange for those products. The Company’s payment terms are typically at the point of sale for merchandise product sales. The Company elected to exclude from revenue taxes assessed by governmental authorities, including value-added and other sales-related taxes, that are imposed on and concurrent with revenue-producing activities. The Company has elected to apply the practical expedient, relative to e-commerce sales, which allows an entity to account for shipping and handling as fulfillment activities, and not a separate performance obligation. Accordingly, the Company recognizes revenue for only one performance obligation, the sale of the product, at shipping point (when the customer gains control). Shipping and handling costs associated with outbound freight are accounted for as fulfillment costs and are included in cost of goods sold. The Company has elected to apply the practical expedient to expense costs as incurred for incremental costs to obtain a contract when the amortization period would have been one year or less. Revenue from merchandise product sales is reported net of sales returns, which includes an estimate of future returns based on historical return rates, with a corresponding reduction to cost of sales. There is judgment in utilizing historical trends for estimating future returns. The Company’s refund liability for sales returns is included in the returns reserve on its condensed consolidated balance sheets and represents the expected value of the refund that will be due to the Company’s customers. The Company also has corresponding assets for recovery that represent the expected net realizable value of the merchandise inventory to be returned. The Company sells stored-value gift cards to customers and offers merchandise credit stored-value cards for certain returns. Such stored-value cards do not have an expiration date. The Company recognizes revenue from stored-value cards when the card is redeemed by the customer. The Company has determined that sufficient evidence exists to support an estimate for stored-value card breakage. Subject to requirements to remit balances to governmental agencies, breakage is recognized as revenue in proportion to the pattern of rights exercised by the customer, which is substantially within thirty-six months from the date of issuance. The amount of breakage recognized in revenue during the thirteen weeks ended March 31, 2024 and April 2, 2023 was not material. The Company has two types of contractual liabilities: (i) cash collections from its customers prior to delivery of products purchased (“deferred revenue”), which are initially recorded within accrued expenses and recognized as revenue when the products are shipped, (ii) unredeemed gift cards and online store credits, which are initially recorded as a stored-value card liability and are recognized as revenue in the period they are redeemed. The following table summarizes the significant changes in the contract liabilities balances included in accrued expenses and other current liabilities during the thirteen weeks ended March 31, 2024 and April 2, 2023 (in thousands): Deferred Stored-Value Revenue Cards Balance as of December 31, 2023 $ 50 $ 13,142 Revenue recognized that was included in contract liability balance at the beginning of the period (50) (1,549) Increase due to cash received, excluding amounts recognized as revenue during the period 230 1,616 Balance as of March 31, 2024 230 13,209 Deferred Stored-Value Revenue Cards Balance as of January 1, 2023 $ 69 $ 10,828 Revenue recognized that was included in contract liability balance at the beginning of the period (69) (1,720) Increase due to cash received, excluding amounts recognized as revenue during the period 122 2,022 Balance as of April 2, 2023 122 11,130 |
Selling and Marketing Expenses | Selling and Marketing Expenses Advertising costs included in selling and marketing expenses were $13.0 million and $15.1 million for the thirteen weeks ended , respectively. |
Net loss Per Share Attributable to Common Stockholders | Net loss Per Share Attributable to Common Stockholders Basic net loss per share attributable to common stockholders is computed using net loss attributable to common stockholders divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share attributable to common stockholders represents net loss attributable to common stockholders divided by the weighted average number of common shares outstanding during the period, including the effects of any dilutive securities outstanding. The following table presents the calculation of basic and diluted weighted average shares used to compute net loss per share attributable to common stockholders: Thirteen Weeks Ended March 31, 2024 April 2, 2023 Weighted average shares used to compute net loss per share attributable to common stockholders – Basic 39,450,502 39,233,953 Dilutive securities: Stock options — — Unvested restricted stock — — Unvested Restricted Stock Units (RSUs) — — Performance Stock Units (PSUs) — — Special compensation awards - — Employee Stock Purchase Plan (ESPP) shares — — 2023 Bonus Plan — — Weighted average shares used to compute net loss per share attributable to common stockholders – Diluted 39,450,502 39,233,953 The following securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (on an as-converted basis): Thirteen Weeks Ended March 31, 2024 April 2, 2023 Stock options 161,397 161,397 Unvested restricted stock 15,617 66,313 Unvested RSUs 4,453,480 4,024,510 PSUs 2,161,571 1,811,571 ESPP shares 161,237 146,535 2023 Bonus Plan 95,912 — Total 7,049,214 6,210,326 |
Goodwill and Intangible Assets | Goodwill and Intangible Assets The Company tests for goodwill impairment at the reporting unit level on the first day of the fourth quarter of each year and between annual tests if significant indicators exist that would suggest the Company's goodwill and intangible assets could potentially be impaired. The Company monitors changing business conditions as well as industry and economic factors, among others, for events which could trigger the need for an interim impairment analysis. The Company concluded that a sustained decline in its stock price coupled with continuing net losses, were significant enough factors to warrant an impairment analysis of its goodwill, tradename and intangible assets (which constitutes the Company's sole reporting unit) during the thirteen weeks ended March 31, 2024. Accordingly, the Company performed an interim quantitative assessment as of March 31, 2024 using a market-based quantitative assessment utilizing a combination of the (i) the guideline public company method applying revenue and EBITDA multiples of similar companies and (ii) the discounted cash flow method. The fair value determination used in the impairment assessment requires estimates of the fair values based on present value or other valuation techniques or a combination thereof, necessitating subjective judgments and assumptions by management. These estimates and assumptions could result in significant differences to the amounts reported if underlying circumstances were to change. The fair value exceeded the carrying value by approximately 17% and the Company concluded that no impairment relating to the goodwill, tradename and intangible assets existed as of March 31, 2024. |
Recently Adopted and Issued Accounting Pronouncements | Recently Adopted Accounting Pronouncements The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. Recently Issued Accounting Pronouncements In November 2023, FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures In December 2023, FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, In March 2024, FASB issued ASU 2024-01, Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards, In March 2024, FASB issued ASU 2024-02, Codification Improvements—Amendments to Remove References to the Concepts Statements, |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Significant Accounting Policies | |
Summary of significant changes in contract liabilities balances | The following table summarizes the significant changes in the contract liabilities balances included in accrued expenses and other current liabilities during the thirteen weeks ended March 31, 2024 and April 2, 2023 (in thousands): Deferred Stored-Value Revenue Cards Balance as of December 31, 2023 $ 50 $ 13,142 Revenue recognized that was included in contract liability balance at the beginning of the period (50) (1,549) Increase due to cash received, excluding amounts recognized as revenue during the period 230 1,616 Balance as of March 31, 2024 230 13,209 Deferred Stored-Value Revenue Cards Balance as of January 1, 2023 $ 69 $ 10,828 Revenue recognized that was included in contract liability balance at the beginning of the period (69) (1,720) Increase due to cash received, excluding amounts recognized as revenue during the period 122 2,022 Balance as of April 2, 2023 122 11,130 |
Schedule of basic and diluted weighted average shares used to compute net loss per share | Thirteen Weeks Ended March 31, 2024 April 2, 2023 Weighted average shares used to compute net loss per share attributable to common stockholders – Basic 39,450,502 39,233,953 Dilutive securities: Stock options — — Unvested restricted stock — — Unvested Restricted Stock Units (RSUs) — — Performance Stock Units (PSUs) — — Special compensation awards - — Employee Stock Purchase Plan (ESPP) shares — — 2023 Bonus Plan — — Weighted average shares used to compute net loss per share attributable to common stockholders – Diluted 39,450,502 39,233,953 |
Schedule of securities that were excluded from computation of diluted net loss per share | Thirteen Weeks Ended March 31, 2024 April 2, 2023 Stock options 161,397 161,397 Unvested restricted stock 15,617 66,313 Unvested RSUs 4,453,480 4,024,510 PSUs 2,161,571 1,811,571 ESPP shares 161,237 146,535 2023 Bonus Plan 95,912 — Total 7,049,214 6,210,326 |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Balance Sheet Components | |
Schedule of property and equipment, net | Property and equipment, net consisted of the following (in thousands): Estimated Useful Lives March 31, December 31, in Years 2024 2023 Leasehold improvements 3 - 9 $ 4,875 $ 4,314 Equipment 3 - 7 3,122 3,053 Furniture and fixtures 3 - 7 2,019 2,151 Construction in progress 234 688 Total property and equipment 10,250 10,206 Less: accumulated depreciation and amortization (5,556) (5,494) Property and equipment, net $ 4,694 $ 4,712 |
Schedule of accrued expenses and other current liabilities | Accrued expenses and other current liabilities consisted of the following (in thousands): March 31, December 31, 2024 2023 Accrued compensation and benefits $ 3,633 $ 5,057 Accrued marketing 7,241 5,002 Accrued inventory 12,815 4,151 Accrued freight 2,751 1,940 Other 3,637 2,193 Accrued expenses and other current liabilities $ 30,077 $ 18,343 |
Leases (Tables)
Leases (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Leases | |
Schedule of future minimum lease payments for the Company's operating and financing lease | As of March 31, 2024, the future minimum lease payments for the Company’s operating and finance leases for each of the fiscal years were as follows (in thousands): Fiscal Year: Operating Leases Finance Leases Total 2024 (remaining nine months) $ 4,252 $ 1,006 $ 5,258 2025 6,263 1,504 7,767 2026 4,970 252 5,222 2027 5,138 74 5,212 2028 5,252 6 5,258 Thereafter 6,380 — 6,380 Total undiscounted lease payment 32,255 2,842 35,097 Present value adjustment (5,582) (122) (5,704) Total lease liabilities 26,673 2,720 29,393 Less: lease liabilities, current (4,106) (1,424) (5,530) Lease liabilities, noncurrent $ 22,567 $ 1,296 $ 23,863 |
Equity-Based Compensation (Tabl
Equity-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Equity-Based Compensation | |
Schedule of estimate fair value of purchase rights under ESPP | Expected term (in years) 0.50 to 1.00 Expected volatility 81.95 to 91.30 % Risk-free interest rate 5.03 to 5.34 % Dividend yield - Weighted average fair value per share of ESPP awards granted $ 0.65 to 0.90 |
Summary of stock option activity | A summary of stock option activity is as follows (in thousands, except per share amounts and years): Weighted- Weighted- Average Average Exercise Remaining Aggregate Options Price per Contractual Intrinsic Outstanding Option Life (years) Value Balance as of December 31, 2023 161,397 $ 11.35 7.29 Granted — — — Forfeited — — — Outstanding as of March 31, 2024 161,397 $ 11.35 7.04 Exercisable as of March 31, 2024 161,397 $ 11.35 7.04 $ — Vested and expected to vest as of March 31, 2024 161,397 $ 11.35 7.04 $ — |
Summary of restricted stock and restricted stock units | Unvested Weighted- Restricted Average Fair Stock Value per Share Balance at December 31, 2023 23,379 $ 4.54 Restricted stock granted — — Restricted stock vested (6,727) 4.41 Restricted stock forfeited (1,035) 4.54 Balance at March 31, 2024 15,617 $ 4.17 Weighted- Unvested Average Fair RSUs Value per Share Balance at December 31, 2023 3,568,406 $ 3.14 RSUs granted 1,940,687 2.03 RSUs vested (983,460) 2.71 RSUs forfeited (72,153) 2.71 Balance at March 31, 2024 4,453,480 $ 2.76 |
Summary of performance stock units | Weighted- Unvested Average Fair PSUs Value per Share Balance at December 31, 2023 1,811,571 $ 2.65 PSUs granted 350,000 1.81 PSUs vested — — PSUs forfeited — — Balance at March 31, 2024 2,161,571 $ 2.51 |
Income Taxes (Tables)
Income Taxes (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Income Taxes | |
Schedule of components of the benefit for income taxes | All of the Company’s loss before income taxes is from the United States. The following table presents the components of the benefit for income taxes (in thousands): Thirteen Weeks Ended March 31, April 2, 2024 2023 Loss before benefit for income taxes $ (6,315) $ (6,326) Benefit for income taxes 579 708 Effective tax rate (9.2) % (11.2) % |
Description of Business, Orga_2
Description of Business, Organization and Liquidity (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 | Apr. 02, 2023 | Nov. 30, 2021 | Dec. 31, 2014 |
Subsidiary, Sale of Stock [Line Items] | |||||
Acquired percentage of outstanding common stock of subsidiary by LP | 100% | ||||
Cash and cash equivalents | $ 5,489 | $ 2,506 | $ 7,829 | ||
Revolving line of credit | 6,000 | $ 8,000 | |||
2021 Revolving Facility | |||||
Subsidiary, Sale of Stock [Line Items] | |||||
Principal amount of credit facility | $ 43,700 | $ 50,000 |
Significant Accounting Polici_4
Significant Accounting Policies - Concentration of Credit Risks (Details) - Customer concentration risk - Maximum - customer | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2024 | Apr. 02, 2023 | Dec. 31, 2023 | |
Accounts receivable | |||
Concentration Risk | |||
Concentration risk percentage | 10% | 10% | |
Number of customers | 0 | 0 | |
Revenue | |||
Concentration Risk | |||
Concentration risk percentage | 10% | 10% | |
Number of customers | 0 | 0 |
Significant Accounting Polici_5
Significant Accounting Policies - Revenue Recognition (Details) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 USD ($) item | Apr. 02, 2023 USD ($) | |
Disaggregation of Revenue | ||
Number of performance obligation | item | 1 | |
Practical expedient | true | |
Number of contractual liabilities | item | 2 | |
Maximum | ||
Disaggregation of Revenue | ||
Revenue duration period | 36 months | |
Deferred Revenue | ||
Significant changes in the contract liabilities balances | ||
Beginning Balance | $ 50 | $ 69 |
Revenue recognized that was included in contract liability balance at the beginning of the period | (50) | (69) |
Increase due to cash received, excluding amounts recognized as revenue during the period | 230 | 122 |
Ending Balance | 230 | 122 |
Stored-Value Cards | ||
Significant changes in the contract liabilities balances | ||
Beginning Balance | 13,142 | 10,828 |
Revenue recognized that was included in contract liability balance at the beginning of the period | (1,549) | (1,720) |
Increase due to cash received, excluding amounts recognized as revenue during the period | 1,616 | 2,022 |
Ending Balance | $ 13,209 | $ 11,130 |
Significant Accounting Polici_6
Significant Accounting Policies - Selling and Marketing Expenses (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Apr. 02, 2023 | |
Selling and Marketing Expense. | ||
Significant Accounting Policies | ||
Advertising costs | $ 13 | $ 15.1 |
Significant Accounting Polici_7
Significant Accounting Policies - Basic and Diluted Weighted Average Shares (Details) - shares | 3 Months Ended | |
Mar. 31, 2024 | Apr. 02, 2023 | |
Significant Accounting Policies | ||
Weighted average shares used to compute net income (loss) per share attributable to common stockholders - Basic | 39,450,502 | 39,233,953 |
Weighted average shares used to compute net income (loss) per share attributable to common stockholders - Diluted | 39,450,502 | 39,233,953 |
Significant Accounting Polici_8
Significant Accounting Policies - Anti-dilutive Securities (Details) - shares | 3 Months Ended | |
Mar. 31, 2024 | Apr. 02, 2023 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||
Total | 7,049,214 | 6,210,326 |
Employee Stock Option | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||
Total | 161,397 | 161,397 |
Unvested restricted stock | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||
Total | 15,617 | 66,313 |
Unvested RSUs | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||
Total | 4,453,480 | 4,024,510 |
Performance stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||
Total | 2,161,571 | 1,811,571 |
Employee stock purchase plan shares | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||
Total | 161,237 | 146,535 |
2023 Bonus Plan | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||
Total | 95,912 |
Significant Accounting Polici_9
Significant Accounting Policies - Goodwill and Intangible Assets (Details) | 3 Months Ended |
Mar. 31, 2024 USD ($) | |
Significant Accounting Policies | |
Percentage fair value exceeds carrying value | 17% |
Goodwill and intangibles impairment | $ 0 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) $ in Millions | Mar. 31, 2024 | Nov. 30, 2021 |
2021 Revolving Facility | ||
Fair Value Measurements | ||
Revolving line of credit | $ 43.7 | $ 50 |
Balance Sheet Components - Prop
Balance Sheet Components - Property and Equipment, net (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2024 | Apr. 02, 2023 | Dec. 31, 2023 | |
Property, Plant and Equipment | |||
Total property and equipment | $ 10,250 | $ 10,206 | |
Less: accumulated depreciation and amortization | (5,556) | (5,494) | |
Property and equipment, net | 4,694 | 4,712 | |
Depreciation and amortization | 1,339 | $ 1,121 | |
Leasehold improvements | |||
Property, Plant and Equipment | |||
Total property and equipment | $ 4,875 | 4,314 | |
Leasehold improvements | Minimum | |||
Property, Plant and Equipment | |||
Estimated Useful Lives (in years) | 3 years | ||
Leasehold improvements | Maximum | |||
Property, Plant and Equipment | |||
Estimated Useful Lives (in years) | 9 years | ||
Equipment | |||
Property, Plant and Equipment | |||
Total property and equipment | $ 3,122 | 3,053 | |
Equipment | Minimum | |||
Property, Plant and Equipment | |||
Estimated Useful Lives (in years) | 3 years | ||
Equipment | Maximum | |||
Property, Plant and Equipment | |||
Estimated Useful Lives (in years) | 7 years | ||
Furniture and fixtures | |||
Property, Plant and Equipment | |||
Total property and equipment | $ 2,019 | 2,151 | |
Furniture and fixtures | Minimum | |||
Property, Plant and Equipment | |||
Estimated Useful Lives (in years) | 3 years | ||
Furniture and fixtures | Maximum | |||
Property, Plant and Equipment | |||
Estimated Useful Lives (in years) | 7 years | ||
Construction in progress | |||
Property, Plant and Equipment | |||
Total property and equipment | $ 234 | $ 688 | |
Property and equipment, net. | |||
Property, Plant and Equipment | |||
Depreciation and amortization | $ 800 | $ 700 |
Balance Sheet Components - Accr
Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Accrued Expenses and Other Current Liabilities | ||
Accrued compensation and benefits | $ 3,633 | $ 5,057 |
Accrued marketing | 7,241 | 5,002 |
Accrued inventory | 12,815 | 4,151 |
Accrued freight | 2,751 | 1,940 |
Other | 3,637 | 2,193 |
Accrued expenses and other current liabilities | $ 30,077 | $ 18,343 |
Debt - Outstanding Debt under t
Debt - Outstanding Debt under the New Revolving Facility (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | ||
Nov. 15, 2021 | Nov. 30, 2021 | Mar. 31, 2024 | Apr. 02, 2023 | |
Line of Credit Facility | ||||
Repaid outstanding balance | $ 12,000 | $ 7,000 | ||
2021 Revolving Facility | ||||
Line of Credit Facility | ||||
Revolving line of credit | $ 50,000 | 43,700 | ||
Increase in maximum borrowing capacity amount | 25,000 | |||
Borrowed amount | 10,000 | |||
Repaid outstanding balance | $ 12,000 | |||
Maximum total leverage ratio | 2.50 | |||
Variable commitment fee percent | 0.375% | |||
Interest rate at period end | 7.20% | |||
Weighted average interest rate | 8.30% | |||
Expected increase in interest rate per annum | 2% | |||
2021 Revolving Facility | Maximum | ||||
Line of Credit Facility | ||||
Revolving line of credit | 75,000 | |||
2021 Revolving Facility | Secured overnight financing ("SOFR") rate | ||||
Line of Credit Facility | ||||
Debt instrument applicable margin percent | 1.75% | |||
2021 Revolving Facility | Base Rate | ||||
Line of Credit Facility | ||||
Debt instrument applicable margin percent | 0.75% | |||
2021 Revolving Facility | Federal funds rate | ||||
Line of Credit Facility | ||||
Debt instrument applicable margin percent | 0.50% | |||
2021 Revolving Facility | One month SOFR | ||||
Line of Credit Facility | ||||
Debt instrument applicable margin percent | 1% | |||
Letters of credit | ||||
Line of Credit Facility | ||||
Revolving line of credit | $ 7,500 | |||
Credit facility outstanding | $ 300 | |||
Line of credit remaining borrowing capacity | $ 7,200 |
Debt - Debt Discounts and Issua
Debt - Debt Discounts and Issuance Costs (Details) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
Other non-current assets | ||
Debt Instrument | ||
Unamortized debt issuance costs | $ 0.1 | $ 0.1 |
Leases - Future Minimum Lease P
Leases - Future Minimum Lease Payments (Details) $ in Thousands | Mar. 31, 2024 USD ($) |
Operating Leases | |
2024 (remaining nine months) | $ 4,252 |
2025 | 6,263 |
2026 | 4,970 |
2027 | 5,138 |
2028 | 5,252 |
Thereafter | 6,380 |
Total undiscounted lease payment | 32,255 |
Present value adjustment | (5,582) |
Total lease liabilities | 26,673 |
Less: lease liabilities, current | $ (4,106) |
Operating lease liability current balance sheet position | Lease liabilities, current |
Lease liabilities, noncurrent | $ 22,567 |
Operating lease liability non-current balance sheet position | Lease liabilities, noncurrent |
Finance Leases | |
2024 (remaining nine months) | $ 1,006 |
2025 | 1,504 |
2026 | 252 |
2027 | 74 |
2028 | 6 |
Total undiscounted lease payment | 2,842 |
Present value adjustment | (122) |
Total lease liabilities | 2,720 |
Less: lease liabilities, current | $ (1,424) |
Finance lease liability current balance sheet position | Lease liabilities, current |
Lease liabilities, noncurrent | $ 1,296 |
Finance lease liability non-current balance sheet position | Lease liabilities, noncurrent |
Total operating and finance lease liabilities | |
2024 (remaining nine months) | $ 5,258 |
2025 | 7,767 |
2026 | 5,222 |
2027 | 5,212 |
2028 | 5,258 |
Thereafter | 6,380 |
Total undiscounted lease payment | 35,097 |
Present value adjustment | (5,704) |
Total lease liabilities | 29,393 |
Less: lease liabilities, current | (5,530) |
Lease liabilities, noncurrent | $ 23,863 |
Preferred Stock (Details)
Preferred Stock (Details) - $ / shares | Mar. 31, 2024 | Dec. 31, 2023 |
Preferred Stock | ||
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock issued | 0 | 0 |
Preferred stock outstanding | 0 | 0 |
Common Stock (Details)
Common Stock (Details) | 3 Months Ended | ||
Mar. 31, 2024 Vote $ / shares shares | Dec. 31, 2023 $ / shares shares | Nov. 15, 2021 shares | |
Common stock, shares authorized | 250,000,000 | 250,000,000 | |
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | |
Number of votes per common stock | Vote | 1 | ||
Dividends declared | $ / shares | $ 0 | ||
Employee Stock Option | |||
Common stock reserved for issuance | 161,397 | ||
Employee Stock Purchase Plan | |||
Common stock reserved for issuance | 1,368,288 | 743,803 | |
Omnibus Equity Plan | |||
Common stock reserved for issuance | 1,704,230 | 3,719,000 |
Equity-Based Compensation - Omn
Equity-Based Compensation - Omnibus Equity Plan and ESPP (Details) $ in Millions | 3 Months Ended | |||||
Apr. 01, 2024 shares | Jun. 29, 2023 shares | Apr. 01, 2022 shares | Mar. 31, 2024 USD ($) item shares | Apr. 02, 2023 USD ($) shares | Nov. 15, 2021 shares | |
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Aggregate shares registered | 5,921,056 | |||||
Employee Stock Purchase Plan | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Aggregate shares registered | 384,211 | |||||
Additional shares registered | 800,000 | |||||
Maximum aggregate number of shares reserved for issuance | 1,368,288 | 743,803 | ||||
Percentage of increase in shares reserved for issuance | 1% | |||||
Number of purchase period for awards | item | 2 | |||||
Purchase period for awards | 6 months | |||||
Stock-based compensation expense | $ | $ 0.1 | |||||
Issuance of common stock for employee stock purchase plan (ESPP) (in shares) | 52,043 | 47,502 | ||||
Purchase period | 6 months | |||||
Percentage of discount from lower of stock price | 15% | |||||
Employee Stock Purchase Plan | Tranche 1 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Offering period for awards | 12 months | |||||
Employee Stock Purchase Plan | Tranche 2 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Offering period for awards | 12 months | |||||
RSUs | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock-based compensation expense | $ | $ 1.6 | $ 2.8 | ||||
Unrecognized equity-based compensation expected to be recognized period | 2 years 3 months 18 days | |||||
Omnibus Equity Plan | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Aggregate shares registered | 1,536,845 | |||||
Additional shares registered | 2,000,000 | 3,200,000 | ||||
Maximum aggregate number of shares reserved for issuance | 1,704,230 | 3,719,000 | ||||
Percentage of increase in shares reserved for issuance | 4% | |||||
2023 Bonus Plan | Adjustment | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock-based compensation expense | $ | $ (0.1) | |||||
2023 Bonus Plan | Employees | RSUs | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Vested RSUs were awarded to eligible employees | 95,912 |
Equity-Based Compensation - Ass
Equity-Based Compensation - Assumptions (Details) - Employee Stock Purchase Plan | 3 Months Ended |
Mar. 31, 2024 $ / shares | |
Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Expected term (in years) | 6 months |
Expected volatility | 81.95% |
Risk-free interest rate | 5.03% |
Weighted average fair value per share of ESPP awards granted | $ 0.65 |
Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Expected term (in years) | 1 year |
Expected volatility | 91.30% |
Risk-free interest rate | 5.34% |
Weighted average fair value per share of ESPP awards granted | $ 0.90 |
Equity-Based Compensation - 202
Equity-Based Compensation - 2021 Equity Plan (Details) - 2021 Equity Incentive Plan | 3 Months Ended |
Mar. 31, 2024 shares | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Maximum aggregate number of shares reserved for issuance | 925,000 |
Options expiration period | 10 years |
Equity-Based Compensation - CEO
Equity-Based Compensation - CEO Stock Options and Special Compensation Awards (Details) $ / shares in Units, $ in Millions | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||
Feb. 13, 2023 shares | Apr. 30, 2021 $ / shares shares | Mar. 31, 2024 shares | Apr. 02, 2023 USD ($) shares | Dec. 31, 2023 item shares | |
Employee Stock Option | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Options, Vested and expected to vest | 161,397 | ||||
Mr. McCreight | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Stock options grants in period | 322,793 | ||||
Stock option exercise price | $ / shares | $ 11.35 | ||||
Number of bonus available | item | 2 | ||||
Equity based compensation | $ | $ 0.4 | ||||
Equity-based compensation (in shares) | 208,914 | ||||
Accelerated expenses | $ | $ 1.2 | ||||
Options Outstanding, Forfeited | 161,396 | 161,396 | |||
Options, Vested and expected to vest | 161,397 | ||||
Mr. McCreight | Minimum | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Post-termination vesting exercise period | 90 days | ||||
Mr. McCreight | Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Post-termination vesting exercise period | 3 years | ||||
Mr. McCreight | Service vesting | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Stock options grants in period | 275,133 | ||||
Mr. McCreight | Service and performance vesting | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Stock options grants in period | 47,660 |
Equity-Based Compensation - Sto
Equity-Based Compensation - Stock Option Activity (Details) - Employee Stock Option [Member] - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2024 | Dec. 31, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding | ||
Beginning balance | 161,397 | |
Ending balance | 161,397 | 161,397 |
Options exercisable | 161,397 | |
Options, Vested and expected to vest | 161,397 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | ||
Weighted-average exercise price per option, beginning balance (in dollars per share) | $ 11.35 | |
Weighted-average exercise price per option, ending balance (in dollars per share) | 11.35 | $ 11.35 |
Weighted-average exercise price per option, exercisable (in dollars per share) | 11.35 | |
Weighted-average exercise price per option, vested and expected to vest (in dollars per share) | $ 11.35 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures | ||
Weighted-average remaining contractual life (years) | 7 years 14 days | 7 years 3 months 14 days |
Weighted-average remaining contractual life (years), vested and exercisable | 7 years 14 days | |
Weighted-average remaining contractual life (years), expected to vest | 7 years 14 days |
Equity-Based Compensation - Sum
Equity-Based Compensation - Summary of Restricted Stock, Restricted Stock Units and Performance Stock Units (Details) | 3 Months Ended |
Mar. 31, 2024 $ / shares shares | |
Restricted Stock | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares | |
Balance at the beginning of period | shares | 23,379 |
Stock vested | shares | (6,727) |
Stock forfeited | shares | (1,035) |
Balance at the end of period | shares | 15,617 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | |
Weighted average fair value, beginning | $ / shares | $ 4.54 |
Weighted average fair value, vested | $ / shares | 4.41 |
Weighted average fair value, forfeited | $ / shares | 4.54 |
Weighted average fair value, end | $ / shares | $ 4.17 |
Unvested RSUs | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares | |
Balance at the beginning of period | shares | 3,568,406 |
Stock granted | shares | 1,940,687 |
Stock vested | shares | (983,460) |
Stock forfeited | shares | (72,153) |
Balance at the end of period | shares | 4,453,480 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | |
Weighted average fair value, beginning | $ / shares | $ 3.14 |
Weighted average fair value, granted | $ / shares | 2.03 |
Weighted average fair value, vested | $ / shares | 2.71 |
Weighted average fair value, forfeited | $ / shares | 2.71 |
Weighted average fair value, end | $ / shares | $ 2.76 |
Performance Stock Units | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares | |
Balance at the beginning of period | shares | 1,811,571 |
Stock granted | shares | 350,000 |
Balance at the end of period | shares | 2,161,571 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | |
Weighted average fair value, beginning | $ / shares | $ 2.65 |
Weighted average fair value, granted | $ / shares | 1.81 |
Weighted average fair value, end | $ / shares | $ 2.51 |
Equity-Based Compensation - Res
Equity-Based Compensation - Restricted Stock. Restricted Stock Units, and Performance Stock Units Narrative (Details) $ in Millions | 3 Months Ended | |||||
Feb. 16, 2024 shares | Jan. 09, 2024 shares | Mar. 05, 2023 installment shares | Nov. 15, 2021 shares | Mar. 31, 2024 USD ($) shares | Apr. 02, 2023 USD ($) | |
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Converted from class P units of the Company upon LP liquidation | 1,964,103 | |||||
Vested common stock | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Converted from class P units of the Company upon LP liquidation | 1,536,304 | |||||
Unvested restricted stock | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Converted from class P units of the Company upon LP liquidation | 427,799 | |||||
Equity based compensation | $ | $ 0.1 | $ 0.2 | ||||
Unrecognized equity based compensation | $ | $ 0.3 | |||||
Unrecognized equity-based compensation expected to be recognized period | 6 months 29 days | |||||
Unvested RSUs | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock granted | 1,940,687 | |||||
Equity based compensation | $ | $ 1.6 | 2.8 | ||||
Unrecognized equity-based compensation expense | $ | $ 11.3 | |||||
Unrecognized equity-based compensation expected to be recognized period | 2 years 3 months 18 days | |||||
Unvested RSUs | Executives and Employees | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock granted | 1,914,071 | |||||
Unvested RSUs | Directors | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock granted | 26,616 | |||||
Unvested RSUs | Tiffany Smith | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock granted | 175,000 | |||||
Vesting period | 3 years | |||||
Unvested RSUs | Mark Vos | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock granted | 660,000 | |||||
Unvested RSUs | Laura Deady | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock granted | 152,273 | |||||
Vesting period | 3 years | |||||
Performance Stock Units | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock granted | 350,000 | |||||
Equity based compensation | $ | $ 0.6 | $ 0.2 | ||||
Unrecognized equity-based compensation expected to be recognized period | 1 year 8 months 15 days | |||||
Performance Stock Units | Financial Milestones | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Unrecognized equity-based compensation option | $ | $ 2.1 | |||||
Performance Stock Units | Crystal Landsem | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock granted | 1,811,571 | |||||
Number of equal annual installments | installment | 3 | |||||
Annual installment value | 603,857 | |||||
Performance Stock Units | Mark Vos | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock granted | 300,000 | |||||
Performance Stock Units | Laura Deady | ||||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||||
Stock granted | 50,000 |
Income Taxes - Components of th
Income Taxes - Components of the Benefit for Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Apr. 02, 2023 | |
Income Taxes | ||
Loss before benefit for income taxes | $ (6,315) | $ (6,326) |
Income tax benefit | $ 579 | $ 708 |
Effective tax rate | (9.20%) | (11.20%) |
Income Taxes - Federal Income T
Income Taxes - Federal Income Tax Rate (Details) | 3 Months Ended | |
Mar. 31, 2024 | Apr. 02, 2023 | |
Income Taxes | ||
Federal income tax rate | 21% | 21% |
Related Party Transactions (Det
Related Party Transactions (Details) | 3 Months Ended |
Mar. 31, 2024 shareholder | |
Related Party Transactions | |
Shareholders with ownership interest greater than 10% | 3 |
Aggregate ownership interest | 10% |
Subsequent Events (Details)
Subsequent Events (Details) $ in Millions | May 03, 2024 USD ($) |
Subsequent event | |
Subsequent Event [Line Items] | |
Stock Repurchase Program Authorized Dollar Amount | $ 2.5 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Apr. 02, 2023 | |
Pay vs Performance Disclosure | ||
Net Income (Loss) | $ (5,736) | $ (5,618) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Mar. 31, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Modified | false |
Rule 10b5-1 Arrangement Modified | false |